Ocular complications of drug therapy.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000337:Aerospace Medicine; D000962:Antimalarials / Q000009:adverse effects; D002738:Chloroquine / Q000009:adverse effects; D002800:Cholinesterase Inhibitors / Q000009:adverse effects; D003261:Contact Lenses / Q000009:adverse effects; D003276:Contraceptives, Oral / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D004781:Environmental Exposure; D005128:Eye Diseases / Q000139:chemically induced*; D005260:Female; D005730:Ganglionic Blockers / Q000009:adverse effects; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010100:Oxygen / Q000009:adverse effects; D010276:Parasympatholytics / Q000009:adverse effects; D010277:Parasympathomimetics / Q000009:adverse effects; D012030:Refractive Errors / Q000139:chemically induced; D013449:Sulfonamides / Q000009:adverse effects
D000305:Adrenal Cortex Hormones; D000962:Antimalarials; D002800:Cholinesterase Inhibitors; D003276:Contraceptives, Oral; D005730:Ganglionic Blockers; D010276:Parasympatholytics; D010277:Parasympathomimetics; D013449:Sulfonamides; D002738:Chloroquine; D010100:Oxygen